Study to Evaluate Absorption, Metabolism and Excretion of Single-dose [14C]-Saroglitazar in Healthy Male Subjects
Clinical trial NCT04112446 · COMPLETED
Trial details
- NCT number
- NCT04112446
- Sponsor
- Zydus Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-20
- Primary completion
- 2019-10-29
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.